À la découverte de l'ézétimibe = EzetimibeWATKINS, C.La Lettre du cardiologue. 2004, Num 378, pp 44-45, issn 0761-5035, 2 p.Article

Ezetimibe-Associated Immune ThrombocytopeniaPATTIS, Peter; WIEDERMANN, Christian J.The Annals of pharmacotherapy. 2008, Vol 42, Num 3, pp 430-433, issn 1060-0280, 4 p.Article

Simultaneous Liquid Chromatographic Determination of Ezetimibe and Simvastatin in Pharmaceutical ProductsRENATO OLIVEIRA, Paulo; BARTH, Thiago; TODESCHINI, Vitor et al.Journal of AOAC International. 2007, Vol 90, Num 6, pp 1566-1572, issn 1060-3271, 7 p.Article

Effectiveness of Thrice Weekly EzetimibeVENERO, Carmelo V; VENERO, Jose V; SEIP, Richard L et al.The American journal of cardiology. 2008, Vol 102, Num 9, pp 1205-1206, issn 0002-9149, 2 p.Article

Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection : Quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bileSHAIK JAFAR SADIK BASHA; SHAIK ABDUL NAVEED; SRINIVAS, Nuggehally R et al.Journal of chromatography. B. 2007, Vol 853, Num 1-2, pp 88-96, issn 1570-0232, 9 p.Article

Effects of Mixed Micellar Lipids on Carotenoid Uptake by Human Intestinal Caco-2 CellsKOTAKE-NARA, Eiichi; NAGAO, Akihiko.Bioscience, biotechnology, and biochemistry. 2012, Vol 76, Num 5, pp 875-882, issn 0916-8451, 8 p.Article

Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibeDERKS, Michael; ABT, Markus; PHELAN, Mary et al.British journal of clinical pharmacology. 2010, Vol 70, Num 6, pp 825-833, issn 0306-5251, 9 p.Article

Données récentes sur l'EzetimibeCAZAUBON, M; AZAR, R.Angéiologie (Paris). 2010, Vol 62, Num 4, pp 42-43, issn 0003-3049, 2 p.Article

Ezetimibe Is an Inhibitor of Tumor AngiogenesisSOLOMON, Keith R; PELTON, Kristine; BOUCHER, Kelly et al.The American journal of pathology. 2009, Vol 174, Num 3, pp 1017-1026, issn 0002-9440, 10 p.Article

Diastereoselective reduction of 1-(4-fluorophenyl)-3(R)-[3-oxo-3-(4-fluorophenyl)-propyl]-4(S)-(4-hydroxyphenyl)azetidin-2-one to Ezetimibe by the whole cell catalyst Rhodococcus fascians MO22KYSLIKOVA, Eva; BABIAK, Peter; MARESOVA, Helena et al.Journal of molecular catalysis. B, Enzymatic. 2010, Vol 67, Num 3-4, pp 266-270, issn 1381-1177, 5 p.Article

In-vitro characterization of the six clustered variants of NPC1 L1 observed in cholesterol low absorbersYAMANASHI, Yoshihide; TAKADA, Tappei; SUZUKI, Hiroshi et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 11, pp 884-892, issn 1744-6872, 9 p.Article

Structure of the major degradant of ezetimibeSANTA, Zsuzsanna; KOTI, Janos; SZOKE, Katalin et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 58, pp 125-129, issn 0731-7085, 5 p.Article

Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1OSWALD, Stefan; KÖNIG, Jörg; LÜTJOHANN, Dieter et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 7, pp 559-568, issn 1744-6872, 10 p.Article

L'ézétimibe (Ezetrol®) : le partenaire des statines = Ezetimibe (Ezetrol®): the statins' partnerDUCOBU, J; STERNON, J.Revue médicale de Bruxelles. 2004, Vol 25, Num 5, pp 456-461, issn 0035-3639, 6 p.Article

Ezetimibe for management of hypercholesterolemiaMAURO, Vincent F; TUCKERMAN, Chad E.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 839-848, issn 1060-0280, 10 p.Article

Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactionsKOSOGLOU, Teddy; STATKEVICH, Paul; JOHNSON-LEVONAS, Amy O et al.Clinical pharmacokinetics. 2005, Vol 44, Num 5, pp 467-494, issn 0312-5963, 28 p.Article

Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of simvastatin and ezetimibe from their combination drug productsCHAUDHARI, Bharat G; PATEL, Natvarlal M; SHAH, Paresh B et al.Journal of AOAC International. 2007, Vol 90, Num 5, pp 1242-1249, issn 1060-3271, 8 p.Article

Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibeZIAJKA, Paul E; REIS, Mary; KREUL, Sandra et al.The American journal of cardiology. 2004, Vol 93, Num 6, pp 779-780, issn 0002-9149, 2 p.Article

Application of one-step liquid chromatography-electrospray tandem MS/MS and collision-induced dissociation to quantification of ezetimibe and identification of its glucuronated metabolite in human serum: A pharmacokinetic studyBAHRAMI, Gholamreza; MOHAMMADI, Bahareh; PYMAN MALEK KHATABI et al.Journal of chromatography. B. 2010, Vol 878, Num 28, pp 2789-2795, issn 1570-0232, 7 p.Article

Effect of apolipoprotein E genotypes on the efficacy of ezetimibe monotherapy in patients with statin induced adverse effectsHARANGI, Mariann; SERES, Ildikó; BALOGH, István et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 9, pp 746-752, issn 0946-1965, 7 p.Article

Managing the underestimated risk of statin-associated myopathyRALLIDIS, Loukianos S; FOUNTOULAKI, Katerina; ANASTASIOU-NANA, Maria et al.International journal of cardiology. 2012, Vol 159, Num 3, pp 169-176, issn 0167-5273, 8 p.Article

Effects of ezetimibe on atherosclerosis in preclinical modelsDAVIS, Harry R; LOWE, Robert S; NEFF, David R et al.Atherosclerosis. 2011, Vol 215, Num 2, pp 266-278, issn 0021-9150, 13 p.Article

Isolation and structure elucidation of major alkaline degradant of EzetimibeGAJJAR, Anuradha K; SHAH, Vishal D.Journal of pharmaceutical and biomedical analysis. 2011, Vol 55, Num 1, pp 225-229, issn 0731-7085, 5 p.Article

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patientsCHOW, Dominic; CHEN, Huichao; GLESBY, Marshall J et al.AIDS (London). 2009, Vol 23, Num 16, pp 2135-2143, issn 0269-9370, 9 p.Article

Self-nanoemulsifying granules of ezetimibe : Design, optimization and evaluationDIXIT, R. P; NAGARSENKER, M. S.European journal of pharmaceutical sciences. 2008, Vol 35, Num 3, pp 179-188, issn 0928-0987, 10 p.Article